Respiratory monitoring with an acceleration sensor.
Tomohiro Ono, Hideki Takegawa, Tatsuya Ageishi...
https://pubmed.ncbi.nlm.nih.gov/21896964/Actively Recruiting
Led by NHS Greater Clyde and Glasgow · Updated on 2026-04-14
225
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are investigating new ways to monitor breathing and sleep patterns in children, especially those who have trouble tolerating standard diagnostic equipment due to sensory or behavioral issues. The study focuses on children at risk of sleep disordered breathing, premature infants with immature breathing control, and children with epilepsy who may experience breathing problems during or after seizures. The goal is to validate a small, wireless wearable device that can help detect breathing issues and assist in sleep diagnostics and monitoring of apnea related to epilepsy. The study uses a small chest-worn biosensor called Pneumowave, which wirelessly transmits respiratory data to a mobile app for real-time monitoring. This observational study includes three patient groups children undergoing overnight cardiorespiratory polysomnography for sleep evaluation, neonatal inpatients at risk of central apnea, and children in the epilepsy monitoring unit at risk of seizure-related apnea. The device data will be compared alongside standard clinical monitoring equipment to assess its feasibility and usefulness. Participants will wear the Pneumowave device during their usual hospital monitoring, and researchers will collect respiratory waveforms, motion data, and treatment responses over up to two years. Feedback on device usability will be gathered from clinicians, nurses, and patients. The study will help determine if the Pneumowave device can reliably detect abnormal breathing patterns to support diagnosis and treatment in these vulnerable pediatric groups.
CONDITIONS
The PARS Study: Paediatric Advanced Respiratory Service Study - An Observational Diagnostic Feasibility Study
R
Ross J Langley, MBChB BSc PhD MRCPCH
H
Hannah Vennard, MBChB BMSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
NHS Greater Clyde and Glasgow
Lead Sponsor
INNOVATEUK
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Overnight or as per hospital stay duration
Participants undergo diagnostic monitoring using the Pneumowave device alongside standard clinical monitoring to assess respiratory patterns and detect breathing abnormalities.
1 overnight monitoring visit or continuous monitoring during hospital stay
Duration - Up to 2 years
Participants are continuously observed using the Pneumowave device in hospital settings to collect respiratory data and assess device usability over time.
Monitoring throughout hospital admission as applicable
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Tomohiro Ono, Hideki Takegawa, Tatsuya Ageishi...
https://pubmed.ncbi.nlm.nih.gov/21896964/Hannah Vennard, Elise Buchan, Jennifer Miller...
https://pubmed.ncbi.nlm.nih.gov/40887117/M Folke, L Cernerud, M Ekström...
https://pubmed.ncbi.nlm.nih.gov/12892358/Carlo Massaroni, Andrea Nicolò, Daniela Lo Presti...
https://pubmed.ncbi.nlm.nih.gov/30795595/George W Williams, Christy A George, Brian C Harvey...
https://pubmed.ncbi.nlm.nih.gov/27384980/Christopher Voscopoulos, Jordan Brayanov, Diane Ladd...
https://pubmed.ncbi.nlm.nih.gov/23733842/Michael Chu, Thao Nguyen, Vaibhav Pandey...
https://pubmed.ncbi.nlm.nih.gov/31304358/NHS Greater Clyde and Glasgow
Lead Sponsor
INNOVATEUK
Collaborating Sponsor